Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Department of Hepatobiliary Surgery, Hainan General Hospital, Hainan 570311, China.
Hum Pathol. 2019 Jul;89:62-70. doi: 10.1016/j.humpath.2019.04.008. Epub 2019 May 3.
Sinonasal undifferentiated carcinoma (SNUC) is defined as undifferentiated carcinoma of the sinonasal tract without glandular or squamous features and not otherwise classifiable. SNUC is a rare tumor, with a long list of differential diagnoses, and often poses a considerable diagnostic challenge. In addition, recent advances in molecular and immunohistochemistry techniques have recognized several new entities that were previously included in the SNUC category. These include SMARCB1 (INI-1)-deficient carcinoma, NUT (nuclear protein in testis) carcinoma, adamantinoma-like Ewing sarcoma, and the most recently described and rarer SMARCA4 (BRG)-deficient carcinoma. In this study, we retrospectively reviewed 11 cases with an original diagnosis of SNUC. We found that a significant portion of those cases can be reclassified into specific entities, with potential impact on therapy and prognosis because of misclassification in 2 of these cases.
鼻腔鼻窦未分化癌(SNUC)被定义为不具有腺状或鳞状特征且无法归入其他类别的鼻-鼻窦道未分化癌。SNUC 是一种罕见的肿瘤,具有一长串的鉴别诊断,常常带来相当大的诊断挑战。此外,分子和免疫组织化学技术的最新进展已经识别出了一些以前归入 SNUC 类别的新实体。这些实体包括 SMARCB1(INI-1)缺失性癌、NUT(睾丸核蛋白)癌、似造釉细胞瘤的尤文肉瘤,以及最近描述的更为罕见的 SMARCA4(BRG)缺失性癌。在这项研究中,我们回顾性分析了 11 例最初诊断为 SNUC 的病例。我们发现,这些病例中有相当一部分可以重新分类为特定实体,由于其中 2 例的分类错误,可能会对治疗和预后产生影响。